Biodesix (BDSX) Net Income (2019 - 2026)
Biodesix filings provide 8 years of Net Income readings, the most recent being -$8.2 million for Q1 2026.
- On a quarterly basis, Net Income rose 24.42% to -$8.2 million in Q1 2026 year-over-year; TTM through Mar 2026 was -$32.9 million, a 17.69% increase, with the full-year FY2025 number at -$35.6 million, up 16.76% from a year prior.
- Net Income hit -$8.2 million in Q1 2026 for Biodesix, down from -$4.0 million in the prior quarter.
- In the past five years, Net Income ranged from a high of -$4.0 million in Q4 2025 to a low of -$18.8 million in Q1 2023.
- Median Net Income over the past 5 years was -$10.8 million (2025), compared with a mean of -$11.5 million.
- Biggest five-year swings in Net Income: tumbled 150.21% in 2022 and later skyrocketed 52.08% in 2025.
- Biodesix's Net Income stood at -$16.4 million in 2022, then surged by 44.05% to -$9.2 million in 2023, then grew by 8.67% to -$8.4 million in 2024, then skyrocketed by 52.08% to -$4.0 million in 2025, then tumbled by 103.13% to -$8.2 million in 2026.
- The last three reported values for Net Income were -$8.2 million (Q1 2026), -$4.0 million (Q4 2025), and -$9.1 million (Q3 2025) per Business Quant data.